GO:1990144 intrinsic apoptotic signaling pathway in response to hypoxia: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990144 describes the intracellular signaling cascade that triggers apoptotic cell death when oxygen levels fall below normoxia, ending with the execution phase of apoptosis.
• Hypoxia activates this pathway through mitochondrial outer membrane permeabilization, governed by Bcl-2 family proteins such as BAX, BAK, and Bcl-xL.
• The pathway is distinct from extrinsic apoptosis and is often modulated by hypoxia-induced autophagy and metabolic adaptation.
• Dysregulation of this pathway contributes to placental pathology, cancer radioresistance, stroke, and melanoma progression.
• Key experimental models include hypoxia chambers, BAK/BAX knockout cells, and Bcl-2/Bcl-xL inhibitor treatments such as ABT-263.
• CRISPR knockout, point mutation, knock-in, and overexpression cell models enable causal dissection of genes in this pathway.
Description
The intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144) is a biological process in which low oxygen tension initiates intracellular signals that culminate in apoptotic cell death. Hypoxia, defined as a decline in oxygen below normoxic levels of 20.8 to 20.95 percent, triggers metabolic adaptation at both cellular and organismal levels, and when adaptation fails, this pathway eliminates damaged cells. This process is central to development, tissue homeostasis, and disease, as it determines whether hypoxic cells survive or die. Researchers study GO:1990144 to understand how oxygen deprivation causes cell death in the placenta, heart, brain, and tumors. The pathway is mechanistically distinct from extrinsic apoptosis because it originates from intracellular stress signals, primarily at the mitochondria. In cancer, hypoxia-driven apoptosis resistance is a major cause of radiotherapy failure, making this pathway a therapeutic target. In stroke and neurodegeneration, inappropriate activation contributes to neuronal loss. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental methods used to study GO:1990144.
intrinsic apoptotic signaling pathway in response to hypoxia At A Glance
| GO ID | GO:1990144 |
|---|---|
| GO term | intrinsic apoptotic signaling pathway in response to hypoxia |
| Ontology | biological_process |
| Synonym | none |
| Major function | Intracellular signaling that triggers apoptotic death in response to lowered oxygen tension |
| Pathway type | Intrinsic (mitochondrial) apoptosis |
| Trigger | Hypoxia, defined as O2 below 20.8-20.95% |
| Endpoint | Execution phase of apoptosis |
| Key regulators | Bcl-2 family proteins including BAX, BAK, Bcl-xL, and BH3-only proteins |
What Is GO:1990144?
GO:1990144 is defined as the series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell, induced in response to hypoxia, which is a decline in oxygen levels below normoxic levels of 20.8 to 20.95 percent. The pathway ends when the execution phase of apoptosis is triggered. In simpler terms, it is the cell's internal death program switched on by low oxygen, operating through mitochondrial and Bcl-2 family signaling rather than through external death receptors.
Why Is intrinsic apoptotic signaling pathway in response to hypoxia Important in Cell Biology?
GO:1990144 is important because it links oxygen sensing to cell fate decisions that underlie major human diseases, including placental insufficiency, ischemic stroke, cancer radioresistance, and melanoma. Understanding this pathway helps researchers design interventions that either promote cell death in tumors or prevent it in neurons and placental tissue.
• Placental apoptosis in response to hypoxia is critical for normal pregnancy and is dysregulated in preeclampsia and fetal growth restriction.
• Hypoxia-induced apoptosis in the heart shows biphasic responses that may inform cardioprotection strategies.
• Bcl-2/Bcl-xL inhibition by ABT-263 overcomes hypoxia-driven radioresistance in cancer.
• Ras family GTPase signaling modulates neuroprotective versus apoptotic outcomes in stroke.
• Loss of BAK causes pronounced apoptosis resistance to intrinsic pathway stimuli.
• Hypoxia regulates TRAIL sensitivity through mitochondrial autophagy in colorectal cancer.
• Neuroglobin supports neuronal survival under hypoxia, opposing intrinsic apoptosis.
• Macroautophagy in melanoma intersects with apoptotic signaling under metabolic stress.
• The pathway is a target for radiosensitizers and chemotherapeutic strategies.
• CRISPR models enable causal testing of genes in this pathway for drug discovery.
What Happens During intrinsic apoptotic signaling pathway in response to hypoxia?
Hypoxia sensing and metabolic adaptation
In simple terms: When oxygen drops, cells first try to adapt by changing their metabolism.
Hypoxia is defined as a decline in O2 levels below normoxic levels of 20.8 to 20.95 percent, and cells respond with metabolic adaptation at both cellular and organismal levels. In the placenta, hypoxia-induced apoptosis is part of normal turnover but becomes pathological when excessive. In the heart, short-term intermittent hypoxia induces biphasic apoptotic responses, indicating that adaptation and death signals are temporally separated. This early phase determines whether the cell survives or commits to apoptosis.
Mitochondrial outer membrane permeabilization
In simple terms: The mitochondria decide whether to release death signals.
The intrinsic pathway converges on mitochondrial outer membrane permeabilization, which is controlled by Bcl-2 family proteins. The additional loss of Bak, but not lack of p56/Lck, caused pronounced apoptosis resistance in response to intrinsic pathway stimuli, demonstrating that BAK is a critical effector. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistance, showing that anti-apoptotic Bcl-2 proteins restrain this pathway under hypoxia. Thus, the balance between pro-apoptotic BAX/BAK and anti-apoptotic Bcl-2/Bcl-xL sets the threshold for apoptosis.
Caspase activation and execution phase
In simple terms: Once the mitochondria leak, caspases dismantle the cell.
Following mitochondrial permeabilization, the pathway ends when the execution phase of apoptosis is triggered, which involves caspase activation. In placental apoptosis, this execution phase contributes to tissue remodeling under hypoxic conditions. In JCaM1.6 subclones, resistance to intrinsic pathway stimuli correlated with failure to activate downstream caspases. The execution phase is the irreversible step that completes GO:1990144.
Cross-talk with autophagy
In simple terms: Autophagy can either protect cells or help them die under hypoxia.
Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy, linking autophagic machinery to intrinsic apoptotic signaling. In malignant melanoma, macroautophagy has basic and clinical implications that intersect with apoptotic pathways. This cross-talk means that GO:1990144 is not isolated but integrated with metabolic stress responses.
Modulation by neuroprotective signaling
In simple terms: Some signaling pathways try to block hypoxia-induced death in neurons.
Ras family small GTPase-mediated neuroprotective signaling in stroke counteracts intrinsic apoptotic pathways. Neuroglobin and neuronal cell survival mechanisms also oppose hypoxia-induced apoptosis. These modulators are important because they determine whether hypoxic neurons die or survive.
Key Genes Involved in GO:1990144 intrinsic apoptotic signaling pathway in response to hypoxia
The following genes and proteins are experimentally implicated in the intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144).
| Gene | Major Role | Research Relevance |
|---|---|---|
| BAX | Pro-apoptotic effector, mitochondrial permeabilization | Knockout models test requirement for intrinsic apoptosis |
| BAK | Pro-apoptotic effector, mitochondrial permeabilization | Loss causes pronounced apoptosis resistance |
| BCL2L1 (Bcl-xL) | Anti-apoptotic guardian | Inhibited by ABT-263 to overcome radioresistance |
| BCL2 | Anti-apoptotic guardian | Target of BH3 mimetics in hypoxia |
| CASP3 | Executioner caspase | Marker of apoptosis execution phase |
| CASP9 | Initiator caspase | Apoptosome-dependent activation |
| CYCS | Cytochrome c release | Mitochondrial permeabilization readout |
| NGB | Neuroglobin, neuronal survival | Opposes hypoxia-induced apoptosis |
| HRAS | Ras GTPase neuroprotective signaling | Modulates stroke outcomes |
| MAPK1 | Downstream kinase signaling | Stress response integration |
| BECN1 | Autophagy regulator | Cross-talk with apoptosis |
| ATG5 | Autophagy machinery | Mitochondrial autophagy under hypoxia |
| TRAIL (TNFSF10) | Death ligand sensitivity | Regulated by hypoxia and autophagy |
| HIF1A | Hypoxia-inducible factor | Master transcription factor for hypoxia adaptation |
| TP53 | Stress sensor | Can promote intrinsic apoptosis |
| BAX/BAK double knockout | Complete block of intrinsic apoptosis | Tool for pathway dissection |
How Is intrinsic apoptotic signaling pathway in response to hypoxia Regulated?
The intrinsic apoptotic signaling pathway in response to hypoxia is regulated at multiple levels. Bcl-2 family proteins, including Bcl-2 and Bcl-xL, set the threshold for mitochondrial outer membrane permeabilization, and their inhibition by ABT-263 sensitizes hypoxic cancer cells to radiotherapy. BAK is required for efficient intrinsic apoptosis, as its loss causes pronounced resistance. Hypoxia-induced autophagy can modulate TRAIL sensitivity in colorectal cancer, adding another layer of regulation. Neuroprotective signaling through Ras family GTPases and neuroglobin can suppress the pathway in neurons. These regulatory nodes are potential therapeutic targets.
intrinsic apoptotic signaling pathway in response to hypoxia and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BAX/BAK | Apoptosis resistance in cancer | Knockout cell lines with hypoxia treatment |
| BCL2L1 | Hypoxia-driven radioresistance | Overexpression and ABT-263 treatment |
| NGB | Neuroprotection in stroke | Neuronal overexpression models |
| HRAS | Ischemic stroke outcomes | Ras signaling knockout models |
| BECN1 | Colorectal cancer TRAIL sensitivity | Autophagy knockout under hypoxia |
Placental pathology and pregnancy disorders
Placental apoptosis in health and disease is linked to hypoxia, and excessive intrinsic apoptosis contributes to pregnancy complications such as preeclampsia and fetal growth restriction. Studying GO:1990144 in trophoblasts may reveal targets for preserving placental function.
Cancer radioresistance
Hypoxia drives radioresistance in tumors, and Bcl-2/Bcl-xL inhibitor ABT-263 overcomes this by promoting intrinsic apoptosis. Hypoxia also regulates TRAIL sensitivity through mitochondrial autophagy in colorectal cancer, affecting treatment response. Targeting GO:1990144 is a strategy to radiosensitize hypoxic tumors.
Stroke and neurodegeneration
In stroke, Ras family small GTPase-mediated neuroprotective signaling counteracts intrinsic apoptotic pathways, and neuroglobin supports neuronal survival under hypoxia. Excessive activation of GO:1990144 contributes to neuronal loss, making it a target for neuroprotection.
Melanoma and metabolic stress
Malignant melanoma shows a gluttonous side involving macroautophagy, which intersects with apoptotic signaling under hypoxia. Understanding GO:1990144 in melanoma may inform combination therapies.
From intrinsic apoptotic signaling pathway in response to hypoxia-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is BAK required for hypoxia-induced apoptosis? | BAK knockout cells |
| Can Bcl-xL inhibition overcome radioresistance? | BCL2L1 overexpression plus ABT-263 |
| Does neuroglobin protect neurons from hypoxia? | NGB overexpression in neuronal cells |
| How does autophagy modulate TRAIL sensitivity? | BECN1 knockout colorectal cancer cells |
| What is the biphasic response to intermittent hypoxia? | In vivo murine heart model |
| Does Ras signaling protect against stroke? | HRAS point mutation models |
How to Study the intrinsic apoptotic signaling pathway in response to hypoxia Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hypoxia chamber + Annexin V | Apoptosis induction | Quantify GO:1990144 activation |
| Caspase 3/9 activity assay | Execution phase | Confirm intrinsic apoptosis |
| Cytochrome c release | Mitochondrial permeabilization | Assess BAX/BAK function |
| JC-1 staining | Mitochondrial membrane potential | Detect early apoptosis |
| LC3 turnover | Autophagic flux | Study cross-talk |
| CRISPR knockout | Gene requirement | Test BAK dependence |
| ABT-263 treatment | Bcl-2/Bcl-xL inhibition | Overcome radioresistance |
| In vivo intermittent hypoxia | Biphasic apoptotic response | Cardiac studies |
Hypoxia chamber and apoptosis assays
Researchers use hypoxia chambers to expose cells to defined low oxygen levels and measure apoptosis by caspase activity, Annexin V, or TUNEL. These assays quantify the execution phase of GO:1990144.
Mitochondrial function assays
Mitochondrial outer membrane permeabilization is assessed by cytochrome c release, JC-1 staining, or Bax/Bak activation status. These methods pinpoint the commitment step of the intrinsic pathway.
Autophagy flux analysis
Because autophagy cross-talks with apoptosis under hypoxia, LC3 turnover and mitophagy reporters are used to measure autophagic flux. This helps distinguish survival autophagy from death-promoting autophagy.
CRISPR-based genetic dissection
CRISPR knockout, point mutation, and knock-in models allow causal testing of genes such as BAX, BAK, and BCL2L1 in hypoxia-induced apoptosis. These models are essential for target validation.
How CRISPR Can Be Used to Study GO:1990144 intrinsic apoptotic signaling pathway in response to hypoxia
Knockout
CRISPR knockout of BAX or BAK is used to test their requirement in hypoxia-induced intrinsic apoptosis, as loss of BAK caused pronounced apoptosis resistance. Knockout of BCL2L1 can sensitize cells to ABT-263 under hypoxia.
Point Mutation
Point mutations in genes such as HRAS are used to dissect neuroprotective signaling in stroke models, where Ras family GTPase activity modulates apoptosis. These models help separate signaling from effector functions.
Knock-in
Knock-in of tagged BAX or BAK allows live-cell imaging of mitochondrial translocation under hypoxia. Tagged knock-in of NGB can track neuroglobin localization in neurons.
Overexpression
Overexpression of BCL2L1 or NGB is used to test protection against hypoxia-induced apoptosis. Overexpression of BECN1 can modulate autophagic cross-talk with apoptosis.
How EDITGENE Supports intrinsic apoptotic signaling pathway in response to hypoxia Research
Researchers studying intrinsic apoptotic signaling pathway in response to hypoxia-related genes often need to determine whether a candidate gene is causally involved in hypoxia-induced cell death or survival. EDITGENE provides CRISPR-based cell model services to enable this causal dissection.
Contact EDITGENE today to design your custom CRISPR model for intrinsic apoptotic signaling pathway in response to hypoxia research.
Frequently Asked Questions About intrinsic apoptotic signaling pathway in response to hypoxia
What is GO:1990144?
GO:1990144 is the intrinsic apoptotic signaling pathway in response to hypoxia, a biological process where low oxygen triggers intracellular signals that lead to apoptotic cell death.
What genes are involved in intrinsic apoptotic signaling pathway in response to hypoxia?
Key genes include BAX, BAK, BCL2L1, BCL2, CASP3, CASP9, CYCS, NGB, HRAS, BECN1, and ATG5.
How does hypoxia induce intrinsic apoptosis?
Hypoxia causes mitochondrial outer membrane permeabilization through Bcl-2 family proteins, leading to caspase activation and apoptosis.
What is the difference between intrinsic and extrinsic apoptosis in hypoxia?
Intrinsic apoptosis originates from intracellular stress signals at the mitochondria, while extrinsic apoptosis is triggered by death receptors.
Which diseases involve GO:1990144?
Placental pathology, cancer radioresistance, stroke, neurodegeneration, and melanoma involve this pathway.
How can I study GO:1990144 in the lab?
Use hypoxia chambers, apoptosis assays, mitochondrial function assays, autophagy flux analysis, and CRISPR models.
What is the role of BAK in hypoxia-induced apoptosis?
Loss of BAK causes pronounced apoptosis resistance to intrinsic pathway stimuli.
Can Bcl-2 inhibitors affect hypoxia-induced apoptosis?
Yes, ABT-263 inhibits Bcl-2/Bcl-xL and overcomes hypoxia-driven radioresistance.
Does autophagy interact with GO:1990144?
Yes, hypoxia regulates TRAIL sensitivity through mitochondrial autophagy in colorectal cancer.
What CRISPR models are available for this pathway?
Knockout, point mutation, knock-in, and overexpression models for genes such as BAX, BAK, BCL2L1, and NGB.
Conclusion
GO:1990144, the intrinsic apoptotic signaling pathway in response to hypoxia, is a central biological process that determines cell fate under low oxygen. Its dysregulation contributes to placental disease, cancer radioresistance, stroke, and melanoma. Mechanistic studies have identified Bcl-2 family proteins, caspases, and autophagy cross-talk as key nodes. CRISPR-based cell models are powerful tools to dissect these mechanisms and identify therapeutic targets.
References
- 1. Sharp AN et al.. 2010. Placental apoptosis in health and disease.. Am J Reprod Immunol 64(3):159-69 PMID: 20367628
- 2. Fiocchetti M et al.. 2013. Neuroglobin and neuronal cell survival.. Biochim Biophys Acta 1834(9):1744-9 PMID: 23357651
- 3. Arbatli S et al.. 2026. Short-term intermittent hypoxia induces biphasic apoptotic responses in the murine heart.. Sci Rep 16(1) PMID: 41882067
- 4. Ritter V et al.. 2021. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.. Cell Death Dis 12(7):694 PMID: 34257274
- 5. Shi GX et al.. 2011. Ras family small GTPase-mediated neuroprotective signaling in stroke.. Cent Nerv Syst Agents Med Chem 11(2):114-37 PMID: 21521171
- 6. Rudner J et al.. 2009. The additional loss of Bak and not the lack of the protein tyrosine kinase p56/Lck in one JCaM1.6 subclone caused pronounced apoptosis resistance in response to stimuli of the intrinsic pathway.. Apoptosis 14(5):711-20 PMID: 19343496
- 7. Checinska A et al.. 2011. The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy.. Pigment Cell Melanoma Res 24(6):1116-32 PMID: 21995431
- 8. Knoll G et al.. 2016. Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy.. Oncotarget 7(27):41488-41504 PMID: 27166192
